CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities:
Net loss	$ (140,591)	$ (105,924)	$ (45,896)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Depreciation and amortization	18,408	26,532	28,666
Amortization of deferred financing costs	1,182	1,543	1,543
Accretion of below- and amortization of above-market lease liabilities and assets, net	(476)	(70)	(8)
Equity-based compensation	408	5,863	8,782
Common stock issued to the Advisor in connection with Advisor related fees	1,610	485	5,013
Common stock issued to directors in lieu of cash for board fees	0	0	62
(Gain)/loss on dispositions of real estate	276	0	0
Impairment of real estate investments	112,541	66,565	0
Changes in assets and liabilities:
Straight-line rent receivable	869	(1,635)	(3,274)
Straight-line rent payable	109	109	110
Prepaid expenses, other assets and deferred costs	238	(1,516)	1,490
Accounts payable, accrued expenses and other liabilities	2,369	871	3,935
Deferred revenue	(942)	(228)	(909)
Net cash provided by (used in) operating activities	(3,999)	(7,405)	(486)
Cash flows from investing activities:
Capital expenditures	(1,291)	(4,059)	(5,555)
Net proceeds from sale of real estate investments	61,148	4,130	0
Net cash provided by (used in) investing activities	59,857	71	(5,555)
Cash flows from financing activities:
Proceeds from issuance of common stock to affiliates of the advisor, net	0	0	1,980
Proceeds from Rights Offering, net (see Note 8)	0	4,059	0
Dividends paid on common stock	0	0	(2,670)
Redemption of fractional shares of common stock and restricted shares	0	(24)	0
Distributions to non-controlling interest holders	0	0	(80)
Common stock shares withheld upon vesting of restricted shares	0	(10)	0
Repurchases of common stock	(231)	0	0
Net cash provided by (used in) financing activities	(49,731)	4,025	(6,270)
Net change in cash, cash equivalents and restricted cash	6,127	(3,309)	(12,311)
Cash, cash equivalents and restricted cash, beginning of period	12,808	16,117	28,428
Cash, cash equivalents and restricted cash, end of period	18,935	12,808	16,117
Cash and cash equivalents	9,776	5,292	9,215
Restricted cash	9,159	7,516	6,902
Supplemental Disclosures:
Cash paid for interest	18,467	17,277	17,396
Non-Cash Investing and Financing Activities:
Common stock issued to the Advisor in connection with management fees	1,610	485	5,013
Net change in accrued capital expenditures for the period	(42)	(683)	780
Related Party
Cash flows from financing activities:
Proceeds from notes payable to related parties	725	0	0
Payment of mortgage note payable	(725)	0	0
Nonrelated Party
Cash flows from financing activities:
Payment of mortgage note payable	$ (49,500)	$ 0	$ (5,500)